New data comparing past vs. present experience with telemedicine during the pandemic uncovers insight on how patients, doctors, and payers view the market post-COVID.
Matthew Heffler
Advertisement
Articles by Matthew Heffler
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
The Insight Gap: Biopharma’s Hidden Risk in the Race Against the Patent Cliff
2
President Trump Planning to Fire FDA Commissioner Marty Makary: Report
3
Marty Makary Out as FDA Commissioner: Report
4
From Consulting to Venture Capital: A Q&A with Gibb Witham, President of Hack The Box
5